Only 1.5% of Africa’s population is fully vaccinated against COVID-19, but according to a recent FiercePharma article, that number is about to go up drastically. The U.S. is investing $200 million in an Aspen Pharmacare manufacturing facility in South Africa to boost the production of the Johnson & Johnson vaccine. The funds will allow the plant to increase capacity far beyond its current rate of 300 million doses per year. J&J has gone on record as saying it is providing its vaccine on a “not-for-profit basis” during the global pandemic, and pledged 500 million doses to the COVAX worldwide relief initiative last December.
U.S. Gives $200M to Boost Vaccines in Africa
The investment will increase production capacity of the J&J vaccine beyond its current rate of 300 million doses per year.
Jul 30, 2021
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
